论文部分内容阅读
肝动脉化疗栓塞术(TACE)是治疗不能手术切除肝癌的首选方法之一,但远期生存率并不理想,其原因有多次TACE后肝功能衰竭且肿瘤完全坏死率低[1,2]。目前介入综合治疗是肝癌治疗的一个方向,我们采用TACE联合经皮肝穿乙醇消融术(PEI)治疗原发性肝癌,并与单纯TACE治疗进行对照分析,从术后肝功能变化、副反应及生存率进行比较,结果如下。1资料与方法1.1临床资料经临床和影像学及免疫学甲胎蛋白(AFP)检查确诊为中晚期肝癌患者72例,男56例,女16例,随机分为两组,单纯组(TACE):36例,男27例,女9例,平均年龄56
Transcatheter Arterial Chemoembolization (TACE) is one of the preferred methods for the treatment of unresectable liver cancer, but the long-term survival rate is not ideal due to multiple post-TACE liver failure and a low rate of complete tumor necrosis [1,2] . Currently involved in comprehensive treatment of liver cancer is a direction of treatment, we use TACE percutaneous transhepatic ethanol ablation (PEI) in the treatment of primary liver cancer, and compared with simple TACE treatment, from the postoperative changes in liver function, side effects and Survival rates were compared, the results are as follows. 1 Materials and Methods 1.1 Clinical data 72 cases of advanced hepatocellular carcinoma diagnosed by clinical and imaging and immunology AFP examination, 56 males and 16 females were randomly divided into two groups, the simple group (TACE) : 36 cases, 27 males and 9 females, with an average age of 56